Simultaneous/JJ
activation/NN
of/IN
Ig/NN
and/CC
Oct-2/NN
synthesis/NN
and/CC
reduction/NN
of/IN
surface/NN
MHC/NN
class/NN
II/CD
expression/NN
by/IN
IL-6/NN
./.

Terminal/JJ
differentiation/NN
of/IN
B/NN
cells/NNS
to/TO
plasma/NN
cells/NNS
in/FW
vivo/FW
is/VBZ
characterized/VBN
by/IN
secretion/NN
of/IN
Ig/NN
and/CC
extinction/NN
of/IN
MHC/NN
class/NN
II/CD
expression/NN
on/IN
the/DT
cell/NN
surface/NN
./.
=====
We/PRP
show/VBP
that/IN
IL-6/NN
signaling/NN
leads/VBZ
to/TO
marked/JJ
increases/NNS
in/IN
the/DT
synthesis/NN
and/CC
secretion/NN
of/IN
Ig/NN
in/IN
clonal/JJ
human/JJ
B/NN
cell/NN
lines/NNS
and/CC
newly/RB
isolated/VBN
polyclonal/JJ
B/NN
lymphocytes/NNS
in/FW
vitro/FW
./.
=====
The/DT
IL-6-induced/JJ
cells/NNS
resemble/VBP
plasma/NN
cells/NNS
in/IN
ultrastructure/NN
and/CC
in/IN
reduced/VBN
expression/NN
of/IN
surface/NN
MHC/NN
class/NN
II/CD
./.
=====
Enhanced/VBN
Ig/NN
synthesis/NN
is/VBZ
a/DT
result/NN
of/IN
coordinated/VBN
transcriptional/JJ
activation/NN
of/IN
Ig/NN
genes/NNS
without/IN
promoter/NN
or/CC
isotype/NN
specificity/NN
,/,
and/CC
differential/JJ
accumulation/NN
of/IN
the/DT
mRNA/NN
encoding/VBG
the/DT
secreted/VBN
form/NN
of/IN
Ig/NN
heavy/JJ
chain/NN
./.
=====
It/PRP
is/VBZ
saturable/JJ
and/CC
subject/JJ
to/TO
negative/JJ
control/NN
when/WRB
IL-6/NN
stimulation/NN
is/VBZ
prolonged/JJ
./.
=====
Coordinate/JJ
with/IN
temporal/JJ
changes/NNS
in/IN
Ig/NN
synthesis/NN
,/,
the/DT
DNA-binding/JJ
activity/NN
and/CC
the/DT
synthesis/NN
of/IN
the/DT
B/NN
cell-enriched/JJ
transcription/NN
factor/NN
Oct-2/NN
are/VBP
regulated/VBN
./.
=====
Thus/RB
,/,
differentiation/NN
of/IN
B/NN
cells/NNS
with/IN
IL-6/NN
in/FW
vitro/FW
recapitulates/VBZ
the/DT
hallmarks/NNS
of/IN
terminal/JJ
B/NN
differentiation/NN
in/FW
vivo/FW
;/:
Oct-2/NN
may/MD
have/VB
a/DT
role/NN
in/IN
this/DT
process/NN
./.